EAM Investors’s Sanara MedTech SMTI Stock Holding History

EAM Investors’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-37,970	Closed	-$1.57M	–	358
2023 Q1	$1.57M	Sell	37,970 -16,792	-31%	-$708K	0.31%	157
2022 Q4	$2.49M	Sell	54,762 -98	-0.2%	-$3.38K	0.52%	60
2022 Q3	$1.63M	Buy	+54,860	New	+$1.54M	0.35%	123

Other funds holding SMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

EAM Investors's SMTI Position: Q2 2023 in Review

EAM Investors sold out of Sanara MedTech (SMTI) in Q2 2023, closing a stake of 37,970 shares — an estimated $1.57M sold.

EAM Investors first reported a position in SMTI in Q3 2022 and held it in 3 quarters. The position peaked at $2.49M in Q4 2022. 47 funds tracked by Wall St. Rank hold SMTI as of Q2 2023.

EAM Investors reported no remaining Sanara MedTech position as of Q2 2023 after selling out during the quarter.
EAM Investors sold 37,970 Sanara MedTech shares in Q2 2023, an estimated $1.57M.
EAM Investors first reported a position in Sanara MedTech in Q3 2022 and held it in 3 quarters.
EAM Investors's Sanara MedTech position peaked at $2.49M in Q4 2022.
47 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2023.

Based on EAM Investors's 13F filing for Q2 2023, filed 11 Aug 2023.